Global Balloon Catheter market is projected to garner revenue worth approximately 16.59 (USD Billion) by 2026 and is set to record a CAGR of more than 5.1% over the period from 2020 to 2026.
The global Balloon Catheter market is projected to garner revenue worth approximately 16.59 (USD Billion) by 2026 and is set to record a CAGR of more than 5.1% over the period from 2020 to 2026. The report offers assessment and analysis of the Balloon Catheter market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).
Balloon catheter is new kind of medical device encompassing guidewire as well as catheter that is implanted into the femoral leg artery or even into the radial artery of the hand-arm for clinically treating confined blood vessels. These products are generally used for preventing blood flow restriction caused as a result of atherosclerosis. Moreover, the medical instrument is used for treating heart ailments including coronary heart disorders occurring owing to hypertension, diabetes, and high blood cholesterol. In addition to this, the product has become a key component of clinical treatment and these instruments find massive utilization in healthcare sector. Citing an instance, AngioSculpt® scoring balloon catheter is an atherotomy Scoring Balloon Catheter is used in coronary & peripheral interventions.
Large-scale occurrence of cardiac disorders and surge in heart intervention methods will boost the market trends. Furthermore, rise in the healthcare funding and favorable compensation policies will further accelerate the business growth over the forthcoming years. Additionally, launching of new balloon catheters and rise in the funding of research activities for manufacturing multi-functional balloon catheters will impel the market trends.
According to WHO, heart ailment is the major cause of death across the globe and results in nearly 17.9 million deaths annually. Reportedly, four out of five deaths occurring as a result of heart disorder are due to heart attack and heart strokes. For the record, one third of the deaths take place in persons below the age of 70. Individuals in high risk zone for heart ailment include those affected due to hypertension, lipids, and glucose. Moreover, these factors are likely to stimulate the growth of balloon catheter market over the years to come. Apparently, growing need for minimally invasive surgeries and introduction of new cardiac procedures will prompt the industry expansion in the years ahead.
Report Attributes | Report Details |
---|---|
Report Name | Balloon Catheter Market |
Market Size in 2020 | USD XX Billion |
Market Forecast in 2026 | USD 16.59 Billion |
Compound Annual Growth Rate | CAGR of 5.1% |
Number of Pages | 110 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | BIOTRONIK SE & Co. KG, Edwards Lifesciences Corporation, Vascular Solutions, Inc., Abbott Laboratories, Johnson & Johnson, Jotech GmbH, Boston Scientific Corporation, MicroPort Scientific Corporation, Medtronic plc, and Teleflex Incorporated. |
Segments Covered | By Product Type, By raw material, By indication, By end-user And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latian America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2019 |
Historical Year | 2015 to 2019 |
Forecast Year | 2020 - 2026 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional market expansion over the forecast timeline is owing to surge in patient consciousness, easy access to advanced healthcare amenities, and presence of robust medical infrastructure facility will embellish the regional market growth trends. Countries like the U.S. and Canada are expected to be the major regional revenue pockets over the years ahead.
Key players influencing the business include BIOTRONIK SE & Co. KG, Edwards Lifesciences Corporation, Vascular Solutions, Inc., Abbott Laboratories, Johnson & Johnson, Jotech GmbH, Boston Scientific Corporation, MicroPort Scientific Corporation, Medtronic plc, and Teleflex Incorporated.
FrequentlyAsked Questions
The key growth drivers that will leverage the market growth include large-scale occurrence of cardiac disorders and surge in heart intervention methods.
The CAGR of the industry is expected to be nearly over 5.1% during the forecast timeline.
North America will contribute remarkably towards the global market share over the estimated timeline.
The key market players include AKVA group, Pentair plc, AquaIndication Systems Technologies LLC, Xylem, Edwards Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Medtronic plc, Jotech GmbH, Johnson & Johnson, Vascular Solutions, Inc., and Teleflex Incorporated.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed